BLACK DIAMOND THERAPEUTICS, INC. Capital Expenditures
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Capital Expenditures of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-06
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $0.00.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $33.00K.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $33.00K, a 82.81% decline from fiscal 2022.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $192.00K, a 92.92% decline from fiscal 2021.
- BLACK DIAMOND THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $2.71M, a 1808.45% increase from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $33.00K derived: sum of 2 quarters · filed 2025-03-06 | $33.00K derived: sum of 3 quarters · filed 2025-03-06 | $33.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $33.00K derived: sum of 2 quarters · filed 2024-11-05 | $33.00K 10-Q · filed 2024-11-05 | $33.00K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | -$8.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-12 | -$8.00K derived: sum of 3 quarters · filed 2024-03-12 | $185.00K derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$8.00K derived: sum of 2 quarters · filed 2024-03-12 | $185.00K derived: sum of 3 quarters · filed 2024-03-12 | $192.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $185.00K derived: sum of 2 quarters · filed 2023-11-06 | $192.00K 10-Q · filed 2023-11-06 | $525.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $200.00K 10-Q · filed 2023-08-11 | $533.00K derived: sum of 3 quarters · filed 2023-08-11 | $2.02M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-09 | $340.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.83M derived: sum of 3 quarters · filed 2023-05-09 | $2.68M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.82M derived: sum of 2 quarters · filed 2023-03-09 | $2.67M derived: sum of 3 quarters · filed 2023-03-09 | $2.71M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.34M derived: sum of 2 quarters · filed 2022-11-08 | $2.38M 10-Q · filed 2022-11-08 | $2.49M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $888.00K 10-Q · filed 2022-08-09 | $997.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.00M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $40.00K 10-Q · filed 2022-05-11 | $149.00K derived: sum of 2 quarters · filed 2022-05-11 | $157.00K derived: sum of 3 quarters · filed 2022-05-11 | $182.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $117.00K derived: sum of 2 quarters · filed 2022-03-17 | $142.00K derived: sum of 3 quarters · filed 2022-03-17 | $142.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $33.00K derived: sum of 2 quarters · filed 2021-11-08 | $33.00K 10-Q · filed 2021-11-08 | $35.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $25.00K 10-Q · filed 2021-08-12 | $27.00K derived: sum of 3 quarters · filed 2021-08-12 | $38.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $2.00K derived: sum of 2 quarters · filed 2021-05-07 | $13.00K derived: sum of 3 quarters · filed 2021-05-07 | $11.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $13.00K derived: sum of 2 quarters · filed 2021-03-25 | $11.00K derived: sum of 3 quarters · filed 2021-03-25 | $21.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $9.00K derived: sum of 2 quarters · filed 2020-11-10 | $19.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $8.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $76.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |